Mikael Dolsten appointed visiting professor at Lund University
By tove [dot] smeds [at] med [dot] lu [dot] se (Tove Smeds) - published 11 December 2020 Mikael Dolsten (Photo: Pfizer) Mikael Dolsten, head of research at Pfizer, who led the development of Pfizer’s and BioNTech’s Covid-19 vaccine, will take up the appointment of visiting professor of Pharmacology at Lund University in Sweden on 1 January 2021. “During my years as a student and researcher in Lund
https://www.medicine.lu.se/article/mikael-dolsten-appointed-visiting-professor-lund-university - 2025-01-27